301 related articles for article (PubMed ID: 16386088)
1. Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations.
Majumdar S; Nashed YE; Patel K; Jain R; Itahashi M; Neumann DM; Hill JM; Mitra AK
J Ocul Pharmacol Ther; 2005 Dec; 21(6):463-74. PubMed ID: 16386088
[TBL] [Abstract][Full Text] [Related]
2. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina.
Kansara V; Hao Y; Mitra AK
J Ocul Pharmacol Ther; 2007 Aug; 23(4):321-34. PubMed ID: 17803430
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, physicochemical properties and antiviral activities of ester prodrugs of ganciclovir.
Patel K; Trivedi S; Luo S; Zhu X; Pal D; Kern ER; Mitra AK
Int J Pharm; 2005 Nov; 305(1-2):75-89. PubMed ID: 16242278
[TBL] [Abstract][Full Text] [Related]
4. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
[TBL] [Abstract][Full Text] [Related]
5. Corneal absorption and anterior chamber pharmacokinetics of dipeptide monoester prodrugs of ganciclovir (GCV): in vivo comparative evaluation of these prodrugs with Val-GCV and GCV in rabbits.
Gunda S; Hariharan S; Mitra AK
J Ocul Pharmacol Ther; 2006 Dec; 22(6):465-76. PubMed ID: 17238815
[TBL] [Abstract][Full Text] [Related]
6. Vitreal pharmacokinetics of dipeptide monoester prodrugs of ganciclovir.
Majumdar S; Kansara V; Mitra AK
J Ocul Pharmacol Ther; 2006 Aug; 22(4):231-41. PubMed ID: 16910863
[TBL] [Abstract][Full Text] [Related]
7. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea.
Anand B; Nashed Y; Mitra A
Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543
[TBL] [Abstract][Full Text] [Related]
8. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
Tirucherai GS; Dias C; Mitra AK
J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
[TBL] [Abstract][Full Text] [Related]
9. Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.
Yang X; Sheng Y; Ray A; Shah SJ; Trinh HM; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2532-2540. PubMed ID: 25775276
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
[TBL] [Abstract][Full Text] [Related]
11. Effect of hydroxypropyl beta cyclodextrin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir.
Tirucherai GS; Mitra AK
AAPS PharmSciTech; 2003; 4(3):E45. PubMed ID: 14621977
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
[TBL] [Abstract][Full Text] [Related]
13. Vitreal pharmacokinetics of peptide-transporter-targeted prodrugs of ganciclovir in conscious animals.
Janoria KG; Boddu SH; Natesan S; Mitra AK
J Ocul Pharmacol Ther; 2010 Jun; 26(3):265-71. PubMed ID: 20565313
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
[TBL] [Abstract][Full Text] [Related]
15. Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium.
Anand BS; Katragadda S; Nashed YE; Mitra AK
Curr Eye Res; 2004; 29(2-3):153-66. PubMed ID: 15512962
[TBL] [Abstract][Full Text] [Related]
16. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
Katragadda S; Gunda S; Hariharan S; Mitra AK
Int J Pharm; 2008 Jul; 359(1-2):15-24. PubMed ID: 18472234
[TBL] [Abstract][Full Text] [Related]
17. Effect of acylation on the ocular disposition of acyclovir. II: Corneal permeability and anti-HSV 1 activity of 2'-esters in rabbit epithelial keratitis.
Hughes PM; Mitra AK
J Ocul Pharmacol; 1993; 9(4):299-309. PubMed ID: 8106836
[TBL] [Abstract][Full Text] [Related]
18. Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs.
Dias CS; Anand BS; Mitra AK
J Pharm Sci; 2002 Mar; 91(3):660-8. PubMed ID: 11920751
[TBL] [Abstract][Full Text] [Related]
19. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399
[TBL] [Abstract][Full Text] [Related]
20. Ocular disposition of novel lipophilic diester prodrugs of ganciclovir following intravitreal administration using microdialysis.
Macha S; Duvvuri S; Mitra AK
Curr Eye Res; 2004 Feb; 28(2):77-84. PubMed ID: 14972713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
